Academic Rank:
Assistant Professor, Department of Medicine, University of British Columbia
Affiliation(s):
BC Cancer Research Centre
Location:
BC Cancer Research Centre
Short Bio
Clinical and Research Roles
- Assistant Professor, Department of Medicine, University of British Columbia
- Clinician Scientist, BC Cancer
- Deputy Head of Department – Department of Lymphoid Cancer Research, BC Cancer Research Centre
- Translational Sciences Co-Chair of the Lymphoma Tumor Group of ECOG
Dr. Scott is an Assistant Professor in the Department of Medicine at the University of British Columbia and a Scientist in the Department of Lymphoid Cancer Research (BC Cancer). He gained his MBChB/PhD from the University of Auckland, New Zealand. Following his clinical fellowships in hematology, he took up a post-doctoral fellowship at BC Cancer with Drs. Gascoyne and Connors. In 2014, he was appointed as a Clinician-Scientist at BC Cancer, receiving the inaugural BC Cancer Foundation Clinical Investigator Award. Dr. Scott’s research focusses on unravelling the determinants of treatment failure in B-cell lymphoid cancers (lymphoma and CLL) and translating this knowledge into assays to guide treatment management. He has authored over 60 peer-reviewed papers, has been an invited speaker at many conferences and receives research funding from Genome Canada, the Terry Fox Research Institute, the Lymphoma Research Foundation and the National Institutes of Health. He is the Clinical Director of BC Cancer’s Centre for Lymphoid Cancer, a member of the Lymphoma/Leukemia Molecular Profiling Project (LLMPP) and the Translational Sciences Co-Chair of the Lymphoma Tumor Group of ECOG.
Academic Backgrounds
Awards & Recognition
Selected Publications
Current Openings & Opportunities
Current Projects In My Lab include
Research
Dr. Scott’s lab focuses on discovery and development of clinically relevant biomarkers to improve disease classification and patient care. Dr. Scott is a member of the Lymphoma/Leukemia Molecular Profiling Project Consortium and is leading a large international project along with distinguished lymphoma clinicians and experts in Cancer Genomics to uncover lymphoma pathogenesis and genomic mechanisms underlying treatment failure in aggressive lymphoma. Also, Dr. Scott is co-leading a large scale applied research project funded by Genome Canada, Genome BC, Canadian Institutes of Health Research and BC Cancer Foundation to address the most significant knowledge gap in lymphoma care; the genome biology of relapsed lymphoid cancers. Dr. Scott has a strong track record of discovery of biomarkers applicable to aggressive B-cell lymphomas and is recognized as an expert in biomarkers and the tumor microenvironment of these diseases. Dr. Scott has developed prognostic and predictive biomarker assays and filed four patents to date, which reflects the true translational nature of his research.